Explore 1B-LSD | TiHKAL · info

Exploring 1B-LSD. To explore a different substance…

Name

1B-LSD

IUPAC names

1-Butanoyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8β-carboxamide
(6aR,9R)-4-Butanoyl-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
(8β)-1-Butanoyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide

ID 7037 · Formula C₂₄H₃₁N₃O₂ · Molecular weight 393.522

InChI InChI=1S/C24H31N3O2/c1-5-9-22(28)27-15-16-13-21-19(18-10-8-11-20(27)23(16)18)12-17(14-25(21)4)24(29)26(6-2)7-3/h8,10-12,15,17,21H,5-7,9,13-14H2,1-4H3/t17-,21-/m1/s1

InChI Key SVRFNPSJPIDUBC-DYESRHJHSA-N This stereoisomer Any stereoisomer

SMILES CCCC(=O)n1cc2c3c1cccc3C1=C[C@H](CN([C@@H]1C2)C)C(=O)N(CC)CC

ChemSpider 82827098
PubChem 145875086
Project Response 1B-LSD (2064-19)
bluelight.org The Small & Handy 1-Bu-LSD Thread
aipsin.com 1B-LSD (Iss. 17, May 2021: VII-115)

Brandt, SD; Kavanagh, PV; Westphal, F; Stratford, A; Elliott, SP; Dowling, G; Wallach, J; Halberstadt, AL. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD). Drug Test. Anal., 13 May 2019, 11 (8), 1122-1133. 1.5 MB. https://doi.org/10.1002/dta.2613 #1B-LSD LC,MS,NMR,IR,UV

Wagmann, L; Richter, LHJ; Kehl, T; Wack, F; Bergstrand, MP; Brandt, SD; Stratford, A; Maurer, HH; Meyer, MR. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Anal. Bioanal. Chem., 1 Jul 2019, 411 (19), 4751-4763. 3.8 MB. https://doi.org/10.1007/s00216-018-1558-9 #14 MS

Elliott, SP; Holdbrook, T; Brandt, SD. Prodrugs of new psychoactive substances (NPS): A new challenge. J. Forensic Sci., 13 Jan 2020, 65 (3), 913-920. 815 kB. https://doi.org/10.1111/1556-4029.14268 #1B-LSD MS,UV

Halberstadt, AL; Chatha, M; Klein, AK; McCorvy, JD; Meyer, MR; Wagmann, L; Stratford, A; Brandt, SD. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD). Neuropharmacology, 1 Nov 2019, 172, 107856. 923 kB. https://doi.org/10.1016/j.neuropharm.2019.107856 #1B-LSD

Brandt, SD; Kavanagh, PV; Westphal, F; Stratford, A; Odland, AU; Klein, AK; Dowling, G; Dempster, NM; Wallach, J; Passie, T; Halberstadt, AL. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Test. Anal., 16 Mar 2020, 12 (6), 812-826. 16.3 MB. https://doi.org/10.1002/dta.2789 #1B-LSD GC,LC,MS,NMR,IR

Tanaka, R; Kawamura, M; Hakamatsuka, T; Kikura-Hanajiri, R. Identification of LSD derivatives, 1cP-LSD, MIPLA and 1B-LSD in illegal products as paper sheet. Yakugaku Zasshi, 1 Nov 2020, 140 (11), 1405–1413. 606 kB. https://doi.org/10.1248/yakushi.20-00124 #4 MS,NMR,UV

Tsochatzis, E; Lopes, JA; Reniero, F; Holland, M; Åberg, J; Guillou, C. Identification of 1-butyl-lysergic acid diethylamide (1B-LSD) in seized blotter paper using an integrated workflow of analytical techniques and chemo-informatics. Molecules, 7 Feb 2020, 25 (3), 712. 5.3 MB. https://doi.org/10.3390/molecules25030712 #1B-LSD

Tanaka, R; Kawamura, M; Mizutani, S; Kikura-Hanajiri, R. Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products. Forensic Toxicol., 21 Feb 2023, n/a. 993 kB. https://doi.org/10.1007/s11419-023-00661-1 #6 LC,MS,NMR,UV

1P-ETH-LAD

A-THPMINACA · AD-THPINACA · ATHPINACA · Adamantyl-THPINACA · SGT-40

(isomer 2) ATHPINACA · 2AD-ATHPINACA · SGT-194

(acetyl) Etonitazene · 5-Acetyletodesnitazene · LS-87139

7 Dec 2019 · · Isomer Design